Studies on Preparation of Osmotic Pump Tablets of Bezafibrate

WU Heng;YNG Xing-gng;ZHNG Zhi-hong;LI Wei;PN Wei-sn

Chinese Pharmaceutical Journal ›› 2008, Vol. 43 ›› Issue (20) : 1574-1578.

Chinese Pharmaceutical Journal ›› 2008, Vol. 43 ›› Issue (20) : 1574-1578.
论著

Studies on Preparation of Osmotic Pump Tablets of Bezafibrate

  • WU Heng,YANG Xing-gang,ZHANG Zhi-hong,LI Wei,PAN Wei-san
Author information +
History +

Abstract

OBJECTIVE To prepare bezafibrate Osmotic Pump Tablets and investigate the factors influencing the drug release.METHODS The Osmotic Pump Tablets were prepared with PEO as drug carriers and Na2CO3 as solubilizing agent.The factors that influenced drug release were examined by single factor investigation.RESULTS The water insoluble model drug of bezafibrate was prepared into Osmotic Pump Tablets.PEO had important effect on the early phase of drug release and Na2CO3 was conducive to the final release.CONCLUSION The preparation of osmotic pump of bezafibrate used small amount adjuvant,in addition,the drug release was stable during 12 h and had obvious characteristic of zero order release.

Key words

bezafibrate / osmotic pump tablets / insoluble drug with large dose / drug release

Cite this article

Download Citations
WU Heng;YNG Xing-gng;ZHNG Zhi-hong;LI Wei;PN Wei-sn. Studies on Preparation of Osmotic Pump Tablets of Bezafibrate [J]. Chinese Pharmaceutical Journal, 2008, 43(20): 1574-1578

References

[1] SANTUS G,BAKER R W. Osmotic drug delivery: A review of the patent literature [J] .J Controlled Release,1995,35 (1):1-21. [2] LIU L X,XU Q,JIANG J S,et al.Unitary-core osmotic pump tablet for controlled release of water-insoluble drug[J] .Acta Pham Sin (药学学报),2003,38 (12):966-967. [3] PRABAKARAN D,SINGH P,KANAUJIA P. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization[J] . Int J Pharm,2004,284 (1-2):95-108. [4] THOMBRE A G. Osmotic drug delivery using swellable-core tech- nology [J] . J Controlled Release,2004,94,(1):75-89. [5] MONK J P, TODD P A. Bezafibrate: A review of its pharmac-odynamic and pharmacokinetic properties and therapeutic use in hyperlipidaemia[J] . Drugs,1987,33 (6): 539-576. [6] LIU C H,XU X Y,CHEN Y,et al. Preparation and in vitro/ in vivo evaluation of bezafibrate sustained-release pellet capsules [J] . J China Pharm Univ (中国药科大学学报),2006,37 (5):419- 422. [7] LI X D,PAN W S,NIE S F,et al. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe [J] . J Controlled Release,2004,96 (3):359-367.

34

Accesses

0

Citation

Detail

Sections
Recommended

/